ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 159 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $39,595 | -62.3% | 61,000 | 0.0% | 0.00% | -66.7% |
Q3 2022 | $105,000 | +38.2% | 61,000 | 0.0% | 0.01% | +50.0% |
Q2 2022 | $76,000 | +90.0% | 61,000 | 0.0% | 0.01% | +200.0% |
Q1 2022 | $40,000 | -39.4% | 61,000 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $66,000 | +17.9% | 61,000 | +96.8% | 0.00% | 0.0% |
Q3 2021 | $56,000 | -31.7% | 31,000 | 0.0% | 0.00% | -20.0% |
Q2 2021 | $82,000 | -26.8% | 31,000 | 0.0% | 0.01% | -37.5% |
Q1 2021 | $112,000 | +43.6% | 31,000 | 0.0% | 0.01% | +60.0% |
Q4 2020 | $78,000 | 0.0% | 31,000 | 0.0% | 0.01% | -16.7% |
Q3 2020 | $78,000 | -23.5% | 31,000 | 0.0% | 0.01% | -25.0% |
Q2 2020 | $102,000 | +37.8% | 31,000 | +3.3% | 0.01% | +14.3% |
Q1 2020 | $74,000 | -43.9% | 30,000 | +7.1% | 0.01% | -30.0% |
Q4 2019 | $132,000 | +10.0% | 28,000 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $120,000 | -26.4% | 28,000 | 0.0% | 0.01% | -28.6% |
Q2 2019 | $163,000 | +40.5% | 28,000 | -6.7% | 0.01% | +40.0% |
Q1 2019 | $116,000 | +107.1% | 30,000 | 0.0% | 0.01% | +66.7% |
Q4 2018 | $56,000 | – | 30,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
SFMG, LLC | 62,433 | $334,000 | 0.07% |
Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |